Brian Agan
Overview
Explore the profile of Brian Agan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
922
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Topper M, Guarnieri J, Haltom J, Chadburn A, Cope H, Frere J, et al.
Proc Natl Acad Sci U S A
. 2024 Nov;
121(49):e2401968121.
PMID: 39602262
Lethal COVID-19 outcomes are attributed to classic cytokine storm. We revisit this using RNA sequencing of nasopharyngeal and 40 autopsy samples from patients dying of SARS-CoV-2. Subsets of the 100...
2.
Mancuso J, Blaylock J, Robinson S, Agan B
MSMR
. 2024 Oct;
31(10):11-16.
PMID: 39467270
Use of HIV pre-exposure prophylaxis (PrEP) among U.S. military service members at high risk for HIV infection remains suboptimal, resulting in preventable new HIV infections and decreased medical readiness among...
3.
Wang W, Bhushan G, Paz S, Stauft C, Selvaraj P, Goguet E, et al.
J Virol
. 2024 Oct;
98(11):e0094824.
PMID: 39365051
Antigenic assessments of SARS-CoV-2 variants inform decisions to update COVID-19 vaccines. Primary infection sera are often used for assessments, but such sera are rare due to population immunity from SARS-CoV-2...
4.
Wang W, Bhushan G, Paz S, Stauft C, Selvaraj P, Goguet E, et al.
bioRxiv
. 2024 May;
PMID: 38712124
Antigenic assessments of SARS-CoV-2 variants inform decisions to update COVID-19 vaccines. Primary infection sera are often used for assessments, but such sera are rare due to population immunity from SARS-CoV-2...
5.
Chien A, Wu T, Lau C, Pandya D, Wiebold A, Agan B, et al.
Ann Neurol
. 2024 Feb;
95(5):941-950.
PMID: 38362961
Objective: To investigate the relationship between neurocognitive deficits and structural changes on brain magnetic resonance imaging in people living with HIV (PLWH) with good virological control on combination antiretroviral therapy,...
6.
Scher A, Berjohn C, Byrne C, Colombo R, Colombo C, Sanchez Edwards M, et al.
Open Forum Infect Dis
. 2022 Jul;
9(7):ofac314.
PMID: 35899278
Background: There is limited information on the functional consequences of coronavirus disease 2019 (COVID-19) vaccine side effects. To support patient counseling and public health messaging, we describe the risk and...
7.
Chaudhary O, Trotta D, Wang K, Wang X, Chu X, Bradley C, et al.
J Immunother Cancer
. 2022 Apr;
10(4).
PMID: 35470232
Background: People living with HIV (PLWH) have increased risk of developing cancers after controlling traditional risk factors and viral suppression. This study explores whether T cells can serve as a...
8.
Carney B, Daniels C, Xu X, Sunil T, Ganesan A, Blaylock J, et al.
AIDS Res Ther
. 2021 May;
18(1):29.
PMID: 33980262
Background: Depression is common among HIV-infected individuals and may contribute to suboptimal adherence to antiretroviral therapy (ART) and subsequent inability to attain viral load (VL) suppression. We evaluated associations between...
9.
Colombo R, Schofield C, Richard S, Fairchok M, Chen W, Danaher P, et al.
J Investig Med
. 2021 Apr;
69(6):1230-1237.
PMID: 33893210
The impact of HIV on influenza-like illness (ILI) has been incompletely described in the era of combination antiretroviral therapy, particularly in the post-H1N1 pandemic period. This analysis informs on ILI...
10.
Revell A, Wang D, Perez-Elias M, Wood R, Cogill D, Tempelman H, et al.
J Antimicrob Chemother
. 2021 Apr;
76(7):1898-1906.
PMID: 33792714
Objectives: With the goal of facilitating the use of HIV-TRePS to optimize therapy in settings with limited healthcare resources, we aimed to develop computational models to predict treatment responses accurately...